Covidien (COV) Tops Q4 EPS by 1c; Reaffirms FY14 Outlook
Tweet Send to a Friend
Covidien (NYSE: COV) reported Q4 EPS of $0.91, $0.01 better ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
